Suchergebnisse

Funding PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). ; Peer reviewed ; Publisher PDF

Funding PIONEER is funded through the IMI2 Joint Undertaking and is listed under Grant Agreement No. 777492 and is part of the Big Data for Better Outcomes Programme (BD4BO). IMI2 receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views communicated within are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein. ; Peer reviewed ; Publisher PDF

Acknowledgements: We are thankful to all the patients and health care professionals who took part in our interview studies and to the patient representatives and advocates who provided insight during our various consensus meetings. We are grateful to Dr. Susie Dodd for her advice in applying the 38-item outcome taxonomy which she and her COMET colleagues developed, and we accept responsibility for any (mis)application. PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint under- taking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. ; Peer reviewed ; Publisher PDF